Zepp Health Future Growth
Future criteria checks 0/6
Zepp Health is forecast to grow earnings and revenue by 55.6% and 5.6% per annum respectively while EPS is expected to grow by 140.1% per annum.
Key information
55.6%
Earnings growth rate
140.1%
EPS growth rate
Electronic earnings growth | 17.5% |
Revenue growth rate | 5.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Nov 2024 |
Recent future growth updates
Recent updates
Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Aug 20Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)
Aug 03Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Apr 17Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Dec 23Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales
Nov 24Can Zepp Health Find Its Way Back Up?
Jul 31Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M
Aug 25What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Aug 12Zepp: Speculative, But With Potentially Great Rewards
Jun 08What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Mar 16Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?
Feb 23Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh
Jan 06When Should You Buy Zepp Health Corporation (NYSE:ZEPP)?
Dec 15Investors Will Want Zepp Health's (NYSE:ZEPP) Growth In ROCE To Persist
Oct 28Globally Minded Zepp Raises Eyebrows With New Ultra-Long Life Smartwatch
Oct 15Zepp: A Solid International Diversification Play
Oct 03Is It Too Late To Consider Buying Zepp Health Corporation (NYSE:ZEPP)?
Sep 13Zepp Health: Taking Over The Smart Health Wearables Market
Jul 14We Think Zepp Health (NYSE:ZEPP) Can Stay On Top Of Its Debt
Jul 07Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 212 | -19 | -8 | N/A | 1 |
12/31/2024 | 178 | -49 | -5 | N/A | 1 |
9/30/2024 | 209 | -39 | N/A | N/A | N/A |
6/30/2024 | 237 | -25 | N/A | N/A | N/A |
3/31/2024 | 296 | -25 | N/A | N/A | N/A |
12/31/2023 | 352 | -30 | 40 | 42 | N/A |
9/30/2023 | 417 | -40 | N/A | N/A | N/A |
6/30/2023 | 492 | -41 | N/A | N/A | N/A |
3/31/2023 | 587 | -49 | N/A | N/A | N/A |
12/31/2022 | 601 | -42 | -116 | -114 | N/A |
9/30/2022 | 665 | -25 | N/A | N/A | N/A |
6/30/2022 | 766 | -16 | N/A | N/A | N/A |
3/31/2022 | 924 | 14 | N/A | N/A | N/A |
12/31/2021 | 983 | 22 | -45 | -37 | N/A |
9/30/2021 | 1,017 | 34 | N/A | N/A | N/A |
6/30/2021 | 1,114 | 38 | N/A | N/A | N/A |
3/31/2021 | 991 | 26 | N/A | N/A | N/A |
12/31/2020 | 986 | 35 | 11 | 24 | N/A |
9/30/2020 | 968 | 47 | N/A | N/A | N/A |
6/30/2020 | 877 | 63 | N/A | N/A | N/A |
3/31/2020 | 861 | 73 | N/A | N/A | N/A |
12/31/2019 | 835 | 82 | 55 | 61 | N/A |
9/30/2019 | 689 | 67 | N/A | N/A | N/A |
6/30/2019 | 603 | 57 | N/A | N/A | N/A |
3/31/2019 | 575 | 58 | N/A | N/A | N/A |
12/31/2018 | 530 | 16 | 93 | 103 | N/A |
9/30/2018 | 462 | 4 | N/A | N/A | N/A |
6/30/2018 | 389 | -10 | N/A | N/A | N/A |
3/31/2018 | 367 | -22 | N/A | N/A | N/A |
12/31/2017 | 315 | 7 | N/A | 37 | N/A |
9/30/2017 | 287 | 8 | N/A | 44 | N/A |
12/31/2016 | 224 | -2 | N/A | 2 | N/A |
12/31/2015 | 138 | -9 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZEPP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ZEPP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ZEPP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ZEPP's revenue (5.6% per year) is forecast to grow slower than the US market (8.8% per year).
High Growth Revenue: ZEPP's revenue (5.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ZEPP's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/31 02:02 |
End of Day Share Price | 2025/01/31 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zepp Health Corporation is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Jing Sun | China Renaissance Securities |
Ang-Chi Lin | Citigroup Inc |
null null | Credit Suisse |